The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP

The development of personalized therapies represents an urgent need owing to the high rate of cancer recurrence and systemic toxicity of conventional drugs. So far, targeted toxins have shown promising results as potential therapeutic compounds. Specifically, toxins conjugated to antibodies or fused...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuppone, S., Assalini, C., Minici, C., Bertagnoli, S., Branduardi, P., Degano, M., Fabbrini, M. S., Montorsi, F., Salonia, A., Vago, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018701/
https://www.ncbi.nlm.nih.gov/pubmed/32054892
http://dx.doi.org/10.1038/s41598-020-59313-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018701/
https://www.ncbi.nlm.nih.gov/pubmed/32054892
http://dx.doi.org/10.1038/s41598-020-59313-8

Ejemplares similares